Filing Details
- Accession Number:
- 0001209191-17-005511
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-25 16:27:31
- Reporting Period:
- 2017-01-23
- Filing Date:
- 2017-01-25
- Accepted Time:
- 2017-01-25 16:27:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1497253 | Organovo Holdings Inc. | ONVO | Biological Products, (No Disgnostic Substances) (2836) | 271488943 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1536583 | Keith Murphy | 6275 Nancy Ridge Drive, Suite 110 San Diego CA 92121 | Chairman, Ceo And President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-01-23 | 4,900 | $3.51 | 6,059,015 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-01-24 | 20,100 | $3.50 | 6,038,915 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sale of shares was effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $3.50 to $3.54. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $3.50 to $3.515. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- This number does not include 1,831,454 shares of common stock underlying oustanding options and 30,000 shares of common stock underlying warrants held by Mr. Murphy; post-transaction Mr. Murphy continues to beneficially own or have a right to acquire 7,900,369 shares of common stock.
Billionaire Hedge Funds
